Asthma
Not recruitingStudy on Benralizumab for Patients with Severe Asthma
Study on Benralizumab for Patients with Severe Asthma
- Disease:Asthma
- Substances:Benralizumab
France- Participants:18–64 years · 65+ years
- Substances:Benralizumab
Rare diseases
Investigational molecules
Locations
Study on Benralizumab for Patients with Severe Asthma
FranceStudy on Long-term Safety of VX-121, Tezacaftor, and Deutivacaftor in Patients with Cystic Fibrosis
FranceStudy on Infertility Risk from Chemotherapy in Young Breast Cancer Patients Using Follitropin Beta and Follitropin Alfa for Egg/Embryo Preservation
FranceStudy on the Effectiveness and Tolerability of Ofatumumab Compared to a Drug Combination for Patients with Newly Diagnosed Relapsing Multiple Sclerosis
FranceStudy on the Effectiveness and Safety of Olorofim vs. Liposomal Amphotericin B for Patients with Invasive Aspergillosis
FranceStudy of Belzutifan and Palbociclib for Patients with Advanced Renal Cell Carcinoma
FranceStudy on Ravulizumab for Adults with Immunoglobulin A Nephropathy (IgAN) to Preserve Kidney Function
FranceStudy on the Safety and Effectiveness of Polatuzumab Vedotin with Rituximab, Gemcitabine, and Oxaliplatin for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
FranceStudy of Lurbinectedin Alone or with Irinotecan for Patients with Relapsed Small Cell Lung Cancer
FranceStudy on Adjusting Enoxaparin Dose for Children with Kidney Transplants to Prevent Blood Clots
FranceStudy on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis
FranceStudy on the Effectiveness and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Children with Multiple Sclerosis
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.